Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.32 USD | -2.95% | -16.99% | +90.74% |
14/05 | Stephens Starts Sensei Biotherapeutics With Overweight Rating, $5 Price Target | MT |
09/05 | Sensei Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+90.74% | 34.11M | |
+10.80% | 115B | |
+12.20% | 106B | |
-4.47% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-12.77% | 17.56B | |
-40.50% | 17.32B | |
+6.58% | 14.03B | |
+31.11% | 12.13B |
- Stock Market
- Equities
- SNSE Stock
- News Sensei Biotherapeutics, Inc.
- Sensei Biotherapeutics Submits Investigational New Drug Application for Potential Solid Tumor Therapy